Treatment of Vaginal Candidiasis
Phase 2
- Conditions
- Vaginal Candidiasis.Candidiasis of vulva and vagina
- Registration Number
- IRCT2014111920001N1
- Lead Sponsor
- Vice chancellor for research, Mashhad University of medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Married women between 18-49 years old; Patients who had a single sexual partner and they themselves were the only sexual partner of their respective spouse; Women who had not used antibiotics, immunosuppressive drugs, or vaginal drugs 14 days before the study; Patients who were not at pregnancy or breast-feeding stage and did not consume alcohol.
Exclusion criteria: patients with pregnancy, diabetes and immunodeficiency.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vaginal wall secretion. Timepoint: In the first visit and 7 to 14 days after first visit. Method of measurement: By using speculum.
- Secondary Outcome Measures
Name Time Method